| Mrs Barbara G Hardwick, RPH | |
|
3482 Crosswind Dr, Phenix City, AL 36869-3226 | |
| (334) 500-4695 | |
| (334) 352-3317 |
| Full Name | Mrs Barbara G Hardwick |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3482 Crosswind Dr, Phenix City, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760538177 | NPI | - | NPPES |
| 9879 | Other | AL | ALABAMA STATE PHARMACY LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9879 (Alabama) | Primary |
| 183500000X | Pharmacist | PS20483 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Barbara G Hardwick, RPH 1177 Lee Road 852, Opelika, AL 36804-1474 Ph: (334) 271-2489 | Mrs Barbara G Hardwick, RPH 3482 Crosswind Dr, Phenix City, AL 36869-3226 Ph: (334) 500-4695 |
News Archive
A complaint filed in federal court last week "alleges Medtronic Inc. illegally marketed a relatively obscure medical device called a biliary stent in ways not approved by federal regulators," The (Minneapolis-St. Paul) Star Tribune reports.
Cellectis bioresearch, the French genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that the companies have entered into an agreement for the development and commercialization of a bioengineered cell line.
​Older adults diagnosed with brain disorders such as Parkinson's disease often feel a loss of independence because of their lack of mobility and difficulty walking.
Nutritionists trying to influence how much fat an obese woman might eat should take into account food prices, the time it takes to make a meal and the location of grocery stores, says a new study of low-income women in Wisconsin.
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
› Verified 1 days ago
Inna Majdalani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5405 Summerville Rd, Phenix City, AL 36867 Phone: 334-214-4508 | |
Dr. Justin Lee Fussell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4401 Riverchase Dr, Phenix City, AL 36867 Phone: 334-732-3526 Fax: 334-732-3535 | |
Dr. Adam Jameson Syfrett, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 Fax: 334-297-5223 | |
Jack Clifford Golden Jr., PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3700 Us Hwy 280/431n, Phenix City, AL 36867 Phone: 334-291-1814 Fax: 334-291-0773 | |
Dr. Meghan Kelly Hughes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3952 Us Highway 80 W, Phenix City, AL 36870 Phone: 334-214-9129 | |
Dr. Emily Roden Gentry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5405 Summerville Rd, Phenix City, AL 36867 Phone: 334-214-4508 | |
Jennifer Buckner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3952 Us Highway 80 W, Phenix City, AL 36870 Phone: 334-214-9129 |